NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2024
Back to search
Official data from USPTO
MEDPRO SYSTEMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000098048406Class
35, 41, 42, 45
Filing
98048406
Registration
7432933
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/02/2024
Trademark type
Combined
Nice classes
35, 41, 42, 45
Filing date
06/19/2023
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/01/2021
First use in commerce
04/01/2021
Drawing code
3
Owner type
16
Owner location
Mt. Arlington, NJ
Examiner
BLOHM, LINDA
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a rectangle consisting of two interlocking puzzle pieces. The puzzle piece on the left is gray and contains the word "MEDPRO" in white, and the puzzle piece on the right is navy blue and contains the word "SYSTEMS" in white.
Holders and representatives
Holders
MedPro Systems LLC
Representatives
Christine Amara SHERMAN ATLAS SYLVESTER & STAMELMAN LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services for life sciencespharmaceuticalsbiotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program supportreviewing program status and performing gap analysesdrafting programs plansprogram implementation supportdevelopment and improvement of policiesstandard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or codeindustry codelaw or regulation; transparency reporting regulatory submission managementassisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceuticalbiotechnology and medical device companies; business consulting servicestracking and monitoring regulatory requirements for others in the field of life sciencespharmaceuticalsbiotechnologymedical devices for regulatory compliance; business consulting servicescompliance program gap analysis for life sciencespharmaceuticalbiotechnologymedical device companies
Class 41
Consulting services in the nature of conducting trainings for life sciencespharmaceuticalsbiotechnologymedical device companies personnel and partners on pharmaceutical and medical device compliance program requirementsfraud and corruption laws and regulationsindustry codes and best practices; consulting servicesdeveloping and providing trainings for life sciencespharmaceuticalbiotechnologymedical device companies in the field of corporate compliance and transparency programs
Class 42
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with internationalfederalstate and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceuticalbiotechnology and medical device companies in managingvalidating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliancesales and marketing efforts
Class 45
Regulatory compliance consulting in the field of life sciencespharmaceuticalsbiotechnologymedical devices; consulting services to assist life sciencespharmaceuticalbiotechnology and medical device companies in the fields of regulatory compliancecompliance in the areas of aggregate spend disclosure reportingthe Prescription Drug Marketing Actthe Drug Supply Chain Security ActCondition of Participation for Outpatient ServicesStark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciencespharmaceuticalbiotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciencespharmaceuticalbiotechnology and medical device corporate compliance program and transparency program developmentimplementation and support; providing online searchable databases and information concerning historicalcurrent and pending lawsregulationsguidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceuticalbiotechnology and medical device companiesfor entities involved in the drug and device supply chainregarding transparency and aggregate spendmarketingadditional compliance requirements; regulatory compliance consultingreviewingdevelopingtraining on and assisting with the implementation and monitoring of standardspracticesprocedures and policies to support regulatory compliance for companies in the fields of life sciencespharmaceuticalsbiotechnologymedical devices
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2024
PUBO
PUBLISHED FOR OPPOSITION
04/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2024
GNRT
NON-FINAL ACTION E-MAILED
03/01/2024
CNRT
NON-FINAL ACTION WRITTEN
03/01/2024
DOCK
ASSIGNED TO EXAMINER
02/26/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2023
NWAP
NEW APPLICATION ENTERED
06/22/2023
Continuous trademark protection
Get notified about every new filing that threatens MEDPRO SYSTEMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.